Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Xizang Haisco Pharmaceutical Group Co Ltd

+ Add to Watchlist

002653:CH

25.880 CNY 0.730 2.90%

As of 23:30:01 ET on 04/20/2015.

Snapshot for Xizang Haisco Pharmaceutical Group Co Ltd (002653)

Open: 25.400 Day's Range: 25.150 - 26.190 Volume: 3,048,489
Previous Close: 25.150 52wk Range: 16.880 - 29.500 1-Yr Rtn: +36.86%

Stock Chart for 002653

No chart data available.
  • 002653:CH 25.880
  • 1D
  • 1M
  • 1Y
25.150
Interactive 002653 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 002653

Current P/E Ratio (ttm) 61.6190
Estimated P/E(12/2015) 41.7419
Relative P/E vs. SZASHR 1.1731
Earnings Per Share (CNY) (ttm) 0.4200
Est. EPS (CNY) (12/2015) 0.6200
Est. PEG Ratio -
Market Cap (M CNY) 27,957.39
Shares Outstanding (M) 1,080.27
30 Day Average Volume 10,560,060
Price/Book (mrq) 13.2665
Price/Sale (ttm) 23.4145
Dividend Indicated Gross Yield 0.77%
Cash Dividend (CNY) 0.2000
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/22/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 002653

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 002653

Xizang Haisco Pharmaceutical Group Company Limited develops, manufactures and sells drug formulations and active pharmaceutical ingredients. The Company's main products include hepatobiliary disease medication, anti-infective drugs, parenteral nutrition drugs, invert sugar for injection, and other related products.

Wang JunminChairman/PresidentFan XiulianVice President
Zheng WeiVice PresidentDeng XiangVice President
More Company Profile & Key Executives for 002653

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil